Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial
Publication
, Conference
Berwanger, O; Lopes, RDS; De Barros e Silva, PGG; Penna Guimaraes, HP; Kojima, FC; Bezerra Campos, VB; Nakagawa, RH; Damiani, LP; Paisani, D ...
Published in: CIRCULATION
2020
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2020
Volume
142
Issue
24
Start / End Page
E486 / E486
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Berwanger, O., Lopes, R. D. S., De Barros e Silva, P. G. G., Penna Guimaraes, H. P., Kojima, F. C., Bezerra Campos, V. B., … Cavalcanti, A. (2020). Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial. In CIRCULATION (Vol. 142, pp. E486–E486).
Berwanger, Otavio, Renato D Sr Lopes, Pedro Gabriel G. De Barros e Silva, Helio P. Penna Guimaraes, Flavia C. Kojima, Viviane B. Bezerra Campos, Renato H. Nakagawa, et al. “Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial.” In CIRCULATION, 142:E486–E486, 2020.
Berwanger O, Lopes RDS, De Barros e Silva PGG, Penna Guimaraes HP, Kojima FC, Bezerra Campos VB, et al. Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial. In: CIRCULATION. 2020. p. E486–E486.
Berwanger, Otavio, et al. “Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial.” CIRCULATION, vol. 142, no. 24, 2020, pp. E486–E486.
Berwanger O, Lopes RDS, De Barros e Silva PGG, Penna Guimaraes HP, Kojima FC, Bezerra Campos VB, Nakagawa RH, Damiani LP, Paisani D, Santucci E, Valeis N, Laranjeira LN, Pavanello R, Cavalcanti A. Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial. CIRCULATION. 2020. p. E486–E486.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2020
Volume
142
Issue
24
Start / End Page
E486 / E486
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology